Skip to search formSkip to main contentSkip to account menu

Complement Hemolytic Activity Assay

Known as: CH50, Total Hemolytic Activity Assay, Total Hemolytic Complement 50% 
A screening assay for circulating COMPLEMENT PROTEINS. Diluted SERUM samples are added to antibody-coated ERYTHROCYTES and the percentage of cell… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Chronic liver diseases have numerous complications in the children. Low serum complement level is a risk factor for the most… 
1984
1984
Using anti-C3d as a solid phase reagent, C3d fixing circulating immune complexes (CIC) were detected in sera from patients with… 
1984
1984
A micromodification of the CH50 assay of Kabat and Mayer is described in which the total reaction volume has been reduced five… 
1980
1980
Development of human C. system was studied by quantification of total serum hemolytical activity (CH50) and individual levels of… 
1980
1980
Low serum CH50 (s-CH50) levels were found in 16 out of 574 patients with primary renal disease. However, five of these 16… 
1980
1980
Serum and plasma samples taken simultaneously from 560 patients with various diseases were examined for hemolytic complement… 
1978
1978
Total haemolytic complement (CH50) activities of sera obtained from newborn dairy calves and their corresponding dams were… 
1976
1976
Of sixty patients with chronic liver disease, eight with cirrhosis or chronic hepatitis had very low serum CH50 but normal plasma… 
1976
1976
The complement consumption of endotoxin preparations extracted by the trichloroacetic acid or phenol-water method from different… 
1973
1973
We investigated complement in leprosy to detect its possible role in pathogenesis. Complement components, C3 proactivator (C3PA…